deferoxamine has been researched along with Muscle Contraction in 14 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Muscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Iron chelation and iron overload was achieved by deferoxamine mesylate or iron dextran injection." | 8.02 | Iron chelation suppresses secondary bleeding after intracerebral hemorrhage in angiotensin II-infused mice. ( Chen, WX; Feng, H; Ge, HF; Guo, C; Li, CC; Tang, XQ; Wang, B; Wang, J; Xia, M; Yin, Y, 2021) |
| "We examined the effects of subarachnoid hemorrhage (SAH) and treatment with deferoxamine (DFO) or sympathectomy on vascular smooth muscle function, as well as the underlying mechanisms involved, by recording the responses to nor-adrenaline and serotonin in isolated carotid arteries in vitro." | 7.69 | Effect of deferoxamine and sympathectomy on vasospasm following subarachnoid hemorrhage. ( Akgün, M; Göksel, M; Kaya, T; Sarioglu, Y; Solak, O; Utkan, T, 1996) |
| "The role of endothelium-related factors in the pathogenesis of cerebral vasospasm after subarachnoid hemorrhage (SAH) has gained interest since the discovery of EDRF and of endothelin-1 (ET-1)." | 7.69 | Effects of deferoxamine and sympathectomy on endothelin-1-induced contraction and acetylcholine-induced relaxation following subarachnoid hemorrhage in carotid artery. ( Akgün, M; Düzcan, E; Sarioğlu, Y; Utkan, NZ; Utkan, T, 1997) |
| " Iron chelation and iron overload was achieved by deferoxamine mesylate or iron dextran injection." | 4.02 | Iron chelation suppresses secondary bleeding after intracerebral hemorrhage in angiotensin II-infused mice. ( Chen, WX; Feng, H; Ge, HF; Guo, C; Li, CC; Tang, XQ; Wang, B; Wang, J; Xia, M; Yin, Y, 2021) |
| "We examined the effects of subarachnoid hemorrhage (SAH) and treatment with deferoxamine (DFO) or sympathectomy on vascular smooth muscle function, as well as the underlying mechanisms involved, by recording the responses to nor-adrenaline and serotonin in isolated carotid arteries in vitro." | 3.69 | Effect of deferoxamine and sympathectomy on vasospasm following subarachnoid hemorrhage. ( Akgün, M; Göksel, M; Kaya, T; Sarioglu, Y; Solak, O; Utkan, T, 1996) |
| "The role of endothelium-related factors in the pathogenesis of cerebral vasospasm after subarachnoid hemorrhage (SAH) has gained interest since the discovery of EDRF and of endothelin-1 (ET-1)." | 3.69 | Effects of deferoxamine and sympathectomy on endothelin-1-induced contraction and acetylcholine-induced relaxation following subarachnoid hemorrhage in carotid artery. ( Akgün, M; Düzcan, E; Sarioğlu, Y; Utkan, NZ; Utkan, T, 1997) |
| " Dose-response curves were made for each of the additives (n> or =4 for each dose)." | 1.31 | Improving the preservation of isolated rat skeletal muscles stored for 16 hours at 4 degrees C. ( Bär, DP; de Smet, M; de With, MC; Kon, M; Kroese, AB; van der Heijden, EP; Werker, PM, 2000) |
| "Reperfusion injury is a phenomenon complicating microvascular reconstruction." | 1.29 | Limiting impairment of muscle function following ischemia and reperfusion in rabbits. ( Huang, L; Klitzman, B; Panza, W; Serafin, D; Zavitsanos, G, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 10 (71.43) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, J | 1 |
| Tang, XQ | 1 |
| Xia, M | 1 |
| Li, CC | 1 |
| Guo, C | 1 |
| Ge, HF | 1 |
| Yin, Y | 1 |
| Wang, B | 1 |
| Chen, WX | 1 |
| Feng, H | 1 |
| Anuvarbekova, A | 1 |
| Fincan, GS | 1 |
| Vural, IM | 1 |
| Ozger, SI | 1 |
| Ercan, ZS | 1 |
| Utkan, T | 3 |
| Sarioglu, Y | 3 |
| DANIEL, EE | 1 |
| IRWIN, J | 1 |
| Hattori, Y | 1 |
| Imamura, M | 1 |
| Akaishi, Y | 1 |
| Kanno, M | 1 |
| Iesaki, T | 1 |
| Okada, T | 1 |
| Yamaguchi, H | 1 |
| Ochi, R | 1 |
| Vollrath, B | 1 |
| Chan, P | 1 |
| Findlay, M | 1 |
| Cook, D | 1 |
| Zavitsanos, G | 1 |
| Huang, L | 1 |
| Panza, W | 1 |
| Serafin, D | 1 |
| Klitzman, B | 1 |
| Kaya, T | 1 |
| Akgün, M | 2 |
| Göksel, M | 1 |
| Solak, O | 1 |
| Düzcan, E | 1 |
| Utkan, NZ | 1 |
| Nasu, T | 1 |
| Suzuki, N | 1 |
| van der Heijden, EP | 1 |
| Kroese, AB | 1 |
| Werker, PM | 1 |
| de With, MC | 1 |
| de Smet, M | 1 |
| Kon, M | 1 |
| Bär, DP | 1 |
| Tachado, SD | 1 |
| Akhtar, RA | 1 |
| Zhou, CJ | 1 |
| Abdel-Latif, AA | 1 |
| Ratz, PH | 1 |
| Lattanzio, FA | 1 |
| Bény, JL | 1 |
| von der Weid, PY | 1 |
14 other studies available for deferoxamine and Muscle Contraction
| Article | Year |
|---|---|
Iron chelation suppresses secondary bleeding after intracerebral hemorrhage in angiotensin II-infused mice.
Topics: Angiotensin II; Animals; Cerebral Hemorrhage; Deferoxamine; Drug Combinations; Hemoglobins; Hyperten | 2021 |
Investigation of enhancement effects of nicotine on cholinergic neurotransmission in isolated rabbit gastric fundus: role of antioxidants.
Topics: Acetylcholine; Allopurinol; Animals; Antioxidants; Atropine; Cholinergic Fibers; Deferoxamine; Elect | 2010 |
ON THE MECHANISMS WHEREBY EDTA, EGTA, DPTA, OXALATE, DESFERRIOXAMINE, AND 1,10-PHENANTHROLINE AFFECT CONTRACTILITY OF RAT UTERUS.
Topics: Calcium; Chelating Agents; Deferoxamine; Edetic Acid; Egtazic Acid; Female; Humans; Magnesium; Muscl | 1965 |
Inotropic changes induced by fluoroaluminates in rabbit left atrial muscles: possible involvement of G proteins.
Topics: Aluminum; Animals; Atrial Function, Left; Cyclic AMP; Deferoxamine; Dose-Response Relationship, Drug | 1995 |
Inhibition of vasoactive amine induced contractions of vascular smooth muscle by hydrogen peroxide in rabbit aorta.
Topics: Acetylcholine; Animals; Antioxidants; Aorta; Deferoxamine; Depression, Chemical; Endothelium, Vascul | 1994 |
Lazaroids and deferoxamine attenuate the intracellular effects of oxyhaemoglobin in vascular smooth muscle.
Topics: Animals; Antioxidants; Calcium; Cell Line; Cell Survival; Chelating Agents; Chromans; Deferoxamine; | 1995 |
Limiting impairment of muscle function following ischemia and reperfusion in rabbits.
Topics: Animals; Calcium Channel Blockers; Deferoxamine; Dimethyl Sulfoxide; Forelimb; Free Radical Scavenge | 1996 |
Effect of deferoxamine and sympathectomy on vasospasm following subarachnoid hemorrhage.
Topics: Animals; Carotid Arteries; Deferoxamine; Disease Models, Animal; Female; Ischemic Attack, Transient; | 1996 |
Effects of deferoxamine and sympathectomy on endothelin-1-induced contraction and acetylcholine-induced relaxation following subarachnoid hemorrhage in carotid artery.
Topics: Acetylcholine; Animals; Carotid Artery Diseases; Carotid Artery, Common; Deferoxamine; Endothelin-1; | 1997 |
Effects of aluminum ions on K(+)-induced contraction in ileal longitudinal smooth muscle.
Topics: Aluminum; Animals; Calcium; Cations; Chelating Agents; Colon; Deferoxamine; Drug Interactions; Guine | 1998 |
Improving the preservation of isolated rat skeletal muscles stored for 16 hours at 4 degrees C.
Topics: Animals; Antioxidants; Chelating Agents; Chromans; Cryopreservation; Cyclic N-Oxides; Deferoxamine; | 2000 |
Effects of isoproterenol and forskolin on carbachol- and fluoroaluminate-induced polyphosphoinositide hydrolysis, inositol trisphosphate production, and contraction in bovine iris sphincter smooth muscle: interaction between cAMP and IP3 second messenger
Topics: Aluminum; Animals; Carbachol; Cattle; Colforsin; Cyclic AMP; Deferoxamine; Fluorine; Hydrolysis; Ino | 1992 |
L-type Ca2+ channel desensitization by F- reduces PhE-induced increase in [Ca2+]i but not stress.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Hydrogen peroxide: an endogenous smooth muscle cell hyperpolarizing factor.
Topics: Animals; Coronary Vessels; Deferoxamine; Dinoprost; Endothelium, Vascular; Free Radicals; Hydrogen P | 1991 |